Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04075370 · ClinicalTrials.gov registry record
Exploring Compensation to Maintain Cognitive Function in Adults Newly Diagnosed With Brain Cancer
A clinical trial, sponsored by Duke University.
- Completed
- Registry status
- 33
- Enrollment target
NCT04075370 is a clinical trial that has completed, run by Duke University. The registered enrollment target is 33 participants.
The verdict
NCT04075370 has completed, sponsored by Duke University.
- COMPLETED
- Registry status
- 33 participants
- Enrollment target
Study Summary
Recent research indicates that variability in cognitive function for brain tumor survivors may be explained by differences in cognitive reserve (CR) and use of compensatory strategies.However, it is unknown when cognitive function declines or survivors tap into compensation. This longitudinal mixed methods study proposes to explore differences in cognitive function and change over time in newly diagnosed adults with brain cancer prior to, immediately after (within 2 weeks), and 2-3 months after radiation therapy treatment has been completed. Specific aims are to: Aim1: Examine the relationship between objective and subjective cognitive function in subjects newly diagnosed with brain cancer prior to and after XRT. Aim 2: Explore the interrelationship between cognitive function and compensation (neural and behavioral) by high/low CR prior to and after XRT. Aim 3: Describe the trajectory of objective and subjective cognitive function over time by CR, cancer type, and associated treatment-related factors.
Interventions
- OTHER Neuropsychological Testing
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 33 participants |
| Start Date | 2021-07-22 |
| Est. Completion | 2022-12-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04075370
The ClinicalTrials.gov registry entry for NCT04075370 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 33 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Duke University, which has 1,725 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Neuropsychological Testing is the first listed.
NCT04075370 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04075370 about?
NCT04075370 is a clinical study titled "Exploring Compensation to Maintain Cognitive Function in Adults Newly Diagnosed With Brain Cancer". Recent research indicates that variability in cognitive function for brain tumor survivors may be explained by differences in cognitive reserve (CR) and use of compensatory strategies.However, it is unknown when cognitive function declines or survivors tap into compensation. This longitudinal mixed ...
What is the current status of trial NCT04075370?
This trial is currently completed. The enrollment target is 33 participants. The study started on 2021-07-22. Estimated completion is 2022-12-31.
What interventions are being tested in trial NCT04075370?
The interventions under investigation include: Neuropsychological Testing (OTHER).
Who is sponsoring clinical trial NCT04075370?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.